Log in to save to my catalogue

Evaluation of CD30/CD4/CD8 in triple-negative invasive ductal carcinoma of breast in association wit...

Evaluation of CD30/CD4/CD8 in triple-negative invasive ductal carcinoma of breast in association wit...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_445ee56f73ad40dd8b7aa8d211d2724d

Evaluation of CD30/CD4/CD8 in triple-negative invasive ductal carcinoma of breast in association with clinicopathological prognostic factors

About this item

Full title

Evaluation of CD30/CD4/CD8 in triple-negative invasive ductal carcinoma of breast in association with clinicopathological prognostic factors

Publisher

India: Wolters Kluwer India Pvt. Ltd

Journal title

Indian journal of pathology & microbiology, 2018-10, Vol.61 (4), p.500-504

Language

English

Formats

Publication information

Publisher

India: Wolters Kluwer India Pvt. Ltd

More information

Scope and Contents

Contents

Background: Triple-negative breast cancer (TNBC) lacks the benefits of receptor-targeted therapeutic strategies. The limitations in treatment options along with poor patients' outcome heighten the need for novel approaches. Due to recent concentration on the role of biomarkers in prognosis, treatment, and survival of various cancer subtypes, this s...

Alternative Titles

Full title

Evaluation of CD30/CD4/CD8 in triple-negative invasive ductal carcinoma of breast in association with clinicopathological prognostic factors

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_445ee56f73ad40dd8b7aa8d211d2724d

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_445ee56f73ad40dd8b7aa8d211d2724d

Other Identifiers

ISSN

0377-4929

E-ISSN

0974-5130

DOI

10.4103/IJPM.IJPM_67_18

How to access this item